Publication

DNA repair defects and antitumor activity with PARP inhibition: TOPARP, a phase II trial of olaparib in metastatic castration resistant prostate cancer

Mateo, J
; 
Sandhu, S
; 
Miranda, S
; 
Carreira, S
; 
Jain, S
; 
Ralph, C
; 
Protheroe, A
; 
Hussain, S
; 
Jones, R
; 
Elliott, Tony
... show 10 more
Citations
Altmetric:
Abstract
Authors
Mateo, J
Sandhu, S
Miranda, S
Carreira, S
Jain, S
Ralph, C
Protheroe, A
Hussain, S
Jones, R
Elliott, Tony
McGovern, U
Gillman, A
Paulding, C
Mossop, H
Porta, N
Bianchini, D
Zafeiriou, Z
Boysen, G
Nava Rodrigues, D
Flohr, P
Seed, G
Goodall, J
Figueiredo, I
Perez-Lopez, R
Tunariu, N
Omlin, A
Ferraldeschi, R
Kunju, Lakshmi P
Eeles, R
Attard, G
Robinson, D
Chinnaiyan, A
Hall, E
de Bono, J
Affiliation
The Institute of Cancer Research & The Royal Marsden NHS Trust, London
Description
Date
2015-08-02
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
Abstract CT322: DNA repair defects and antitumor activity with PARP inhibition: TOPARP, a phase II trial of olaparib in metastatic castration resistant prostate cancer 2015, 75 (15 Supplement):CT322 Cancer Res
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/606938
Embedded videos